Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Ustekinumab or Golimumab Administered Subcutaneously (SC) in Patients With Sarcoidosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating subcutaneous ustekinumab or golimumab in sarcoidosis has completed and posted results in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoidosis

Drugs mentioned

• Golimumab (golimumab)
• USTEKINUMAB (USTEKINUMAB)

Snippet

Sponsor: Centocor, Inc. | Conditions: Sarcoidosis | Phase 2 | Status: COMPLETED | Results posted: 2014-07-17